Search Results
Feb 26, 2026, 18:59 ET /C O R R E C T I O N -- Caris Life Sciences/
David Spetzler, MS, PhD, MBA, President of Caris Life Sciences. "Most other attempts to derive insights into blood-based early detection modalities have relied upon epigenomics.
More news about: Caris Life Sciences
Feb 26, 2026, 12:50 ET Cerecin Announces Publication of Clinical Study Demonstrating Promising Results of CER-0001 (tricaprilin) for Rare Pediatric Epilepsy
strict dietary intervention."Rare epilepsies such as infantile epileptic spasms represent a major unmet medical need," said Samuel Henderson, PhD, Chief Scientific Officer of Cerecin. "These results support the potential of CER-0001 as a practical metabolic therapy that could provide the
More news about: Cerecin Inc.
Feb 26, 2026, 12:32 ET CULINARY INSTITUTE OF AMERICA ANNOUNCED AS EXCLUSIVE LAUNCH PARTNER FOR MATTSONIQ™
Led by Provost Jeroen Greven, and Vice President of Academic Affairs Michael Sperling, PhD., the lab will be piloted by a select number of CIA faculty and students who will collaborate closely with Steve Gundrum, Mattson's Chief AI Officer,
More news about: The Culinary Institute of America
Feb 26, 2026, 12:07 ET Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
a first-of-its-kind treatment for the millions of patients suffering from the debilitating cognitive effects of schizophrenia," said Amit Etkin, MD, PhD, founder and CEO of Alto Neuroscience. "Our baseline results have already replicated findings from three independent datasets, reinforcing our
More news about: USA News Group
Feb 26, 2026, 11:30 ET Children's Hospital of Philadelphia and Penn Medicine Launch First CRISPR-Based Platform to Pinpoint Drivers of Acute Myeloid Leukemia in Patient Cells
Junwei Shi, PhD, the study's lead author, and an associate professor of Cancer Biology at Penn Medicine. "It helps identify drug-ready targets, shows how different
More news about: Children's Hospital of Philadelphia
Feb 26, 2026, 11:07 ET More Organ Donations Now Come from People Who Die After Their Heart Stops Beating
researchers involved in the study are Jennifer Motter, MHS; Darren Stewart, MS; Sunjae Bae, MD, PhD; Brendan Parent, JD; Bonnie Lonze, MD, PhD; Philip Sommer, MD; Sommer Gentry, PhD; Jeffrey Stern, MD; and Allan Massie, PhD. Husain has received consulting fees from the pharmaceutical company Novartis,
More news about: NYU Grossman School of Medicine and NYU Langone Health
Feb 26, 2026, 10:52 ET Advanced Materials for Vaginal Self-Collection Enabling High-Quality DNA Isolation, Upcoming Webinar Hosted by Xtalks
recovery in human samples and support the development of robust non-invasive sampling devices.Join Paul Slowey, PhD, CEO and Founder, Oasis Diagnostics®; and Ellen Weinzapfel, PhD, Global Marketing Manager,
More news about: Xtalks
Feb 26, 2026, 10:00 ET Transformative Biotech Names Mark Kelleher, PhD as Executive VP of R&D
BOULDER, Colo., Feb. 26, 2026 /PRNewswire/ -- Transformative Biotech has appointed Mark Kelleher, PhD, as Executive Vice President of Research & Development, strengthening the leadership team as it advances its extraction-free PCR platform for infectious
More news about: Transformative Biotech, LLC
Feb 26, 2026, 10:00 ET Expert Analysis Shows What Fragrance Exposure Really Means for Human Health
every day over a lifetime."Hazard describes what a substance might do at different, often extremely high, doses," said Kaushal Joshi, PhD, DABT, RIFM Principal Scientist and study co-author. "Risk reflects what actually happens at real-world levels. This study reinforces why exposure
More news about: Research Institute for Fragrance Materials
Feb 26, 2026, 10:00 ET GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1)
child and family who were courageous in being the first to accept our investigational gene therapy for SMA1," said GEMMABio CEO James M. Wilson, MD, PhD, who also serves as a Member of the International Expert Advisory Board at Brazil's Casa dos Raros ("House of Rare"). "We appreciate our steadfast
More news about: GEMMA Biotherapeutics
Feb 26, 2026, 08:30 ET How an Ecosystem-Driven Electronic Lab Notebook (ELN) Accelerates R&D, Upcoming Webinar Hosted by Xtalks
scientific workflows by connecting partner tools across cloud infrastructure, AI, molecular modeling, chemistry and data intelligence.Rob Brown, PhD, Global VP and Head of the Scientific Office at Sapio Sciences, will discuss how scientific teams are reducing reliance on disconnected point solutions
More news about: Xtalks
Feb 26, 2026, 08:00 ET Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
announced participation at the following investor conferences:TD Cowen 46th Annual Health Care Conference – Dave Lennon, PhD, President and CEO, will participate in a hybrid presentation and fireside chat on Tuesday, March 3 at 10:30 AM ETLeerink
More news about: Whitehawk Therapeutics, Inc.
Feb 26, 2026, 07:30 ET Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
composition of matter for dusquetide and related analogs. Dusquetide was developed pursuant to discoveries made by Professors B. Brett Finlay, PhD and Robert Hancock, PhD of the University of British Columbia, Canada. Dusquetide has been awarded
More news about: SOLIGENIX, INC.
Feb 25, 2026, 18:16 ET Differing immune responses in infants may explain increased severity of RSV over SARS-CoV-2
similar at first glance, but when we examined how immune genes were regulated, we saw striking differences," said co-corresponding author Duygu Ucar, PhD, Professor at JAX. "RSV appears to reprogram parts of the infant immune system at the epigenetic level; which are molecular switches that control how
More news about: St. Jude Children's Research Hospital
Feb 25, 2026, 17:00 ET Being an early bird, getting more physical activity linked to lower risk of ALS
more physical activity may reduce the risk of some neurodegenerative diseases, but results for ALS have been mixed," said study author Hongfu Li, MD, PhD, of Zhejiang University in Hangzhou, China. "Our study found a sleep schedule that better matches daylight hours and more physical activity were related
More news about: American Academy of Neurology
Feb 25, 2026, 15:41 ET FARE and the National Peanut Board Announce a $2.5 Million Investment Over Five Years to Advance Food Allergy Research
collaborative research model designed to accelerate progress against disease. This approach was developed during the tenure of FARE CEO Sung Poblete, PhD, RN, in her prior role leading Stand Up To Cancer for more than a decade. Its application in food allergy aims to accelerate the translation of research
More news about: FARE (Food Allergy Research & Education)
Feb 25, 2026, 15:13 ET APTA Urges Congress to Expand the Physical Therapy Workforce in Rural America
preventing disability, managing chronic conditions, and restoring quality of life for millions of Americans," says APTA President Kyle Covington, PT, DPT, PhD. "It expands access to care where it is needed most, helping ensure that patients in rural and underserved areas can receive the rehabilitative care
More news about: American Physical Therapy Association
Feb 25, 2026, 14:50 ET Inner Circle acknowledges Dr. Melvin T Miller as a Pinnacle Professional Member Inner Circle of Excellence
Administration from the University of South Carolina. He went on to earn an MBA from Webster University, a Master of Philosophy in Management, and a PhD in Applied Management and Decision Sciences from Walden University. His academic journey also includes the "Teaching with Cases" program at Harvard Business
More news about: The Inner Circle
Feb 25, 2026, 11:30 ET Seven Beckman Young Investigators and Five Arnold O. Beckman Postdoctoral Fellows Win Six-Month Bridge Funding Awards to Sustain Research Programs
name)Margaret Byron, PhD2021 Beckman Young InvestigatorThe Pennsylvania State UniversityFluid dynamics of flexibility: deformable bio-structures for locomotion and sensing in complex flowsKatherine Davis, PhD2021 Beckman Young InvestigatorEmory
More news about: Arnold and Mabel Beckman Foundation
Feb 25, 2026, 10:38 ET IMO Health Operationalizes Mondo Rare Disease Knowledge, Bringing Greater Precision to Diagnosis and Research
advancing research."Rare disease patients often experience years of uncertainty before receiving an accurate diagnosis," said Dr. Melissa Haendel, PhD, Director of Precision Health and Translational Informatics at the University of North Carolina School of Medicine and co-founder of the Monarch Initiative.
More news about: Intelligent Medical Objects, Inc.
Feb 25, 2026, 10:00 ET Newly Released Economic Study Finds W.Va. Dog Racing "Does Not Pay for Itself"
breeders at the expense of other vital state programs."The analysis, completed in February 2026, is conducted by Michael J. Hicks, PhD, and Dagney Faulk, PhD. Hicks is the Director of the Center for Business and Economic Research and a G&F Ball Distinguished Professor of Economics at the Miller
More news about: GREY2K USA
Feb 25, 2026, 10:00 ET Avisi Technologies Announces $10.7M Capital Raise to Advance Novel Glaucoma Device Development
clinic.""Avisi Technologies' innovative meta-materials and design engineering tackles the unmet needs of glaucoma patients," said Darren Cai, PhD, MBA, Managing Partner at Sherpa Healthcare Partners. "VisiPlate's unique materials, ultra-thin profile, and multichannel design, has the potential to
More news about: Avisi Technologies
Feb 25, 2026, 09:42 ET ERMProtect Celebrates 28 Years of Cybersecurity Leadership with New Brand Rollout
outsourcing, and on-demand security consulting. The company's training division offers a 100+ module library of Security Awareness Training and in-person, PhD-led sessions that teach organizations how to protect data and incorporate better security.Learn more at
More news about: ERMProtect
Feb 25, 2026, 09:15 ET Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
biomolecular signatures that can improve the diagnosis and prognosis of cancer and even explain how it metastasizes in the body.Dr. Ioannis Vlachos, PhD, director of the
More news about: Illumina, Inc.
Feb 25, 2026, 09:00 ET Foundation Fighting Blindness to Host Free Webinar on Regenerative Medicine Advances for Retinal Diseases
and Ophthalmology (ARVO).Jeff Stern, PhD, MD, is founder and chief medical officer of Luxa Biotechnology, where he is developing dry AMD treatment using RPE cell therapies. A retinal specialist with a PhD in biophysics and an MD in ophthalmology, Dr. Stern is also co-founder
More news about: Foundation Fighting Blindness